Podcasts about treatments

My website My Instagram

Kirsten Eom studies everything that goes into getting a cancer survivor from their front door to a doctor's office: insurance, transportation, follow-up care, and more. The UT Health San Antonio researcher has found that a surprising number of survivors stop seeing doctors once initial treatment ends. Now she's working to build a statewide registry to track the barriers keeping them away.

Today, I am delighted to connect with Dr. Elisa Port, a talented breast surgeon with a passion for helping women better understand breast cancer, breast health, and the science behind screening, diagnosis, and treatment. She's the chief of breast surgery for Mount Sinai Health System in New York, a professor of surgery at Mount Sinai's Icahn School of Medicine, and the author of The Breast Advice. In our conversation, we explore breast cancer risk factors, various screening mechanisms and their impact on dense breasts, and the role of diagnosis and pathology, including DCIS. We also discuss menopause symptom management, anti-hormone and targeted treatments, immunotherapy, de-escalation, and why a personalized approach to breast cancer treatment is so important.  Stay tuned for a truly informative conversation with Dr. Port. With her infectious optimism, she has a wonderful way of translating the science and the research in her book, making it accessible and putting the statistics into context so the information feels far less scary than it otherwise might. IN THIS EPISODE, YOU WILL LEARN: How 90% of women diagnosed with breast cancer have no family cancer history How body weight and alcohol can influence breast cancer risk Why Dr. Port recommends annual mammograms beginning at age 40 for most women Dr. Port may disagree with recommendations against breast self-exams Why women with dense breasts may benefit from supplemental ultrasound or MRI in addition to mammography Unvalidated breast screening tests may lead to false positives, unnecessary testing, procedures, anxiety, and expense. What DCIS is, and how it influences treatment decisions Why an individualized approach is essential when using SERMs, SERDs, and aromatase inhibitors How Oncotype testing helps to identify women who may safely avoid chemotherapy Bio: Dr Elisa Port Dr. Elisa Port, MD, is chief of breast surgery at Mount Sinai Health System, which encompasses seven different breast centers. Her team performs over a thousand breast surgical procedures each year. She is also the director of the Dubin Breast Center, a state-of-the-art breast center in Manhattan that opened in April 2011. She personally consults with thousands of patients and performs hundreds of operations each year. Dr. Port is a trusted voice in the media and a sought-after speaker. She has been featured in The New York Times, NPR, CBS, Today, Mornings with Maria, and Pix11. In addition to her media presence, Dr. Port regularly speaks at public events and is invited to present at conferences and panels across the country. She lives in Manhattan with her husband and two dogs. Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Elisa Port On her website On her personal Instagram  Breast Advice MD on Instagram The Breast Advice Substack

The diabetes drugs that transformed weight loss may be key to treating addiction, too. Dr. Sanjay Gupta speaks with Dr. Dhruv Khullar about how GLP-1s affect the brain, its reward system, and maybe even addiction. This episode was produced by Jennifer Lai with assistance from Sofia Sanchez.  Video production by Ross Helman, Bob Nebel and Jasmine Brooks.  Medical Writer: Andrea Kane  Showrunner: Dan Bloom  Technical Director: Dan Dzula  Sr. Director of Podcasts: Zach Goldbaum  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Money Making Conversations Master Class with Rushion McDonald is America's premier entrepreneurship, business leadership, financial literacy, and wealth-building podcast featuring successful entrepreneurs, executives, founders, celebrities, and industry experts sharing actionable insights for professional and financial success. Business Podcast Entrepreneurship Small Business Business Growth Financial Literacy Wealth Building Black Entrepreneurs Minority Business Leadership Executive Leadership Business Funding Marketing Strategies Personal Development Startup Advice Sales Training CEO Interviews Founder Stories Professional Development Economic Empowerment Business Success Networking Brand Building Innovation How to start a business Small business funding Entrepreneur success stories Business leadership podcast Wealth building strategies Black entrepreneur podcast Minority business development Marketing for small businesses Business growth strategies Startup funding opportunities Executive leadership training Financial literacy education Success mindset podcast Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Dr. Jai Johnson.

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Money Making Conversations Master Class with Rushion McDonald is America's premier entrepreneurship, business leadership, financial literacy, and wealth-building podcast featuring successful entrepreneurs, executives, founders, celebrities, and industry experts sharing actionable insights for professional and financial success. Business Podcast Entrepreneurship Small Business Business Growth Financial Literacy Wealth Building Black Entrepreneurs Minority Business Leadership Executive Leadership Business Funding Marketing Strategies Personal Development Startup Advice Sales Training CEO Interviews Founder Stories Professional Development Economic Empowerment Business Success Networking Brand Building Innovation How to start a business Small business funding Entrepreneur success stories Business leadership podcast Wealth building strategies Black entrepreneur podcast Minority business development Marketing for small businesses Business growth strategies Startup funding opportunities Executive leadership training Financial literacy education Success mindset podcast Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Dr. Jai Johnson.

Another failure of LA posterior wall isolation, first-line AF ablation, a revelation on EAST-AFNET 4 trial, an LAAC meta-analysis, and preventing AKI post-cardiac surgery are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback DAPT-MVD Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2517588 II Another Failure of Posterior Wall Isolation CORNERSTONE-AF Trial https://doi.org/10.1093/eurheartj/ehag486 CAPLA Trial https://jamanetwork.com/journals/jama/fullarticle/2800186 PVIOTAL IDE Trial 10.1016/j.hrthm.2025.08.018 External Link III First Line AF ablation – One new study and a discovery about a second one Catheter Ablation vs AAD for First-line Treatment of AF 10.1016/j.hrthm.2025.07.061 External Link EAST-AFNET 4 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2019422 Cardiology Trials Substack https://cardiologytrials.substack.com/p/summary-and-discussion-of-east-afnet IV Left Atrial Appendage Closure Meta-analysis Long-Term Efficacy and Safety of LAAC vs OAC -- Meta-analysis https://academic.oup.com/europace/article/28/7/euag159/8739567 V Prevention of AKI after Cardiac Surgery: MERCURI-2 MERCURI-2 Study https://jamanetwork.com/journals/jama/fullarticle/2852324 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Full episodes notes are on Dr. Aimee's website. In this episode, I'm shining a spotlight on adenomyosis: a condition that's often misunderstood and overlooked, yet can have a profound impact on fertility and overall uterine health. I'm joined by Dr. Armando Hernandez-Rey, a board-certified reproductive endocrinologist and founder of Conceptions Florida, who is at the forefront of treating complex reproductive health issues, including adenomyosis, endometriosis, and recurrent pregnancy loss. Together, we dive deep into what adenomyosis is, how it differs from endometriosis, why it's so frequently undiagnosed, and what it means for those struggling with infertility or recurrent pregnancy loss. Dr. Hernandez-Rey shares his expertise on diagnosis, treatment options (including the latest in minimally invasive therapies) and how patients can best advocate for themselves. Whether you're newly diagnosed or searching for answers, this conversation is packed with insights to empower you on your fertility journey. In this episode we cover: The difference between adenomyosis and endometriosis, and why that distinction matters Why adenomyosis is often missed or misdiagnosed in fertility workups The impact of adenomyosis on implantation, pregnancy outcomes, and miscarriage risk Diagnostic tools: ultrasound vs. MRI and what to ask your doctor Treatment options, including hormonal therapies and emerging minimally invasive procedures like radiofrequency ablation How to advocate for yourself and what questions to ask your fertility specialist Real-world outcomes and statistics from Dr. Hernandez-Rey's clinical experience Resources: Dr. Armando Hernandez-Rey's practice: Conceptions Florida Do you have questions about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, August 17 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates

How do you decide between a dedicated aortic scaffold and kissing stents in complex aortoiliac bifurcations? On this episode of the BackTable Podcast, Dr. Sabeen Dhand and Dr. Eric Secemsky discuss the management of a female smoker presenting with rapidly progressive bilateral hip pain, ultimately revealed to be severe aortoiliac arterial disease. The case highlights the value of noninvasive vascular studies, CTA, and IVUS for precise diagnosis and procedural planning, as well as the nuanced decision-making process between different device options. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction01:56 - Patient History05:42 - CTA and Angio Findings09:30 - Strategy Access and IVUS13:17 - IVUS Sizing and Lesion Review16:38 - IVL Angioplasty Technique18:28 - Stenting and Final Result22:50 - Post-procedure Meds and Outcome24:34 - Wrap Up --- More about this episode Dr. Secemsky reviews access strategy, lesion sizing, and the use of intravascular lithotripsy to reduce rupture risk in heavily calcified arteries. The doctors explain their rationale for choosing kissing covered stents over a dedicated aortic scaffold, details the technical steps of ballooning and stenting, and discusses the transition from dual antiplatelet therapy to rivaroxaban and aspirin postprocedure. The episode concludes with key insights into device selection, procedural technique, and patient-centered decision-making for successful aortoiliac interventions. --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

As we've interviewed expert clinicians on the podcast, clear trends have emerged. These clinicians have two things in common: They have a pretty set arc to their treatment sessions. They tend to work from “menus” of intervention options. I'm pretty sure they do this- because this is what they've discovered works. But, I've never really seen this approach studied or discussed in research…until now.I was honestly flabbergasted to hear one of the most prominent rehab researchers in the world, talking about these two things, in his paper  Many Paths to Recovery: The Case for Treatment Pluralism. From what I understand, Dr. Cook gives these concepts some formal names: he calls those intervention menus ‘treatment pluralism‘—and he calls the components of the arc of a session ‘therapeutic ritual‘… driven by what researchers call contextual factorsIn today's episode, I can't wait to dig deeper into this paper—and how our guest Dr. Chad Cook currently understands the factors that make therapy effective. This is an episode that could fundamentally change how you think about each patient encounter.  See full course details here:https://otpotential.com/continuing-education/course/msk-treatment-pathways See all OT CEU courses here:https://otpotential.com/ceu-podcast-coursesCheck our our live webinar schedule here:https://otpotential.com/live-ot-ceu-webinarsSupport the show by using the OTPOTENTIAL Medbridge Code:https://otpotential.com/blog/promo-code-for-medbridgeTry 2 free OT Potential courses here:https://otpotential.com/free-ot-ceusSupport the show

We are excited to kick off season 5 of the Just Us: Before, Birth, and Beyond podcast with two peer support extraordinaries, Cassie York and Cassie Burleson. This episode dives deeply into what it means to be a peer support specialist, discussing the unique role they fill in supporting people through recovery. Listen in to learn about how the Cassies' lived experience has allowed them to be such incredible advocates for their patients, processes for becoming a peer support specialist, and more! Resources: North Carolina Certified Peer Support Specialist Program https://www.ncdhhs.gov/cpssapplicationprocess20240425/open North Carolina Certified Peer Support Specialist Program: https://pss.unc.edu/ Scannell C. (2021). Voices of Hope: Substance Use Peer Support in a System of Care. Substance abuse : research and treatment, 15, 11782218211050360. https://doi.org/10.1177/11782218211050360 Center for Health Care Strategies (Jan 2026). Peer Recovery Support Services in Substance Use Treatment. Retrieved from https://www.chcs.org/resource/peer-recovery-support-services-in-substance-use-treatment/ Eddie, D., O'Connor, J.B., George, S.S. et al. Peer Recovery Support Services and Recovery Coaching for Substance Use Disorder: A Systematic Review. Curr Addict Rep 12, 40 (2025). https://doi.org/10.1007/s40429-025-00645-8We would love your feedback on our podcast!  Please take our listener survey to provide your comments. Music credit: "Carefree" Kevin MacLeod (incompetech.com)  Licensed under Creative Commons: By Attribution 4.0 License http://creativecommons.org/licenses/by/4.0/Please provide feedback here:https://redcap.mahec.net/redcap/surveys/?s=XTM8T3RPNK 

Bethany Smith is a fighter.  Almost immediately after surviving Hodgkin lymphoma, she was diagnosed with metastatic follicular thyroid cancer.  In addition to having her thyroid removed, she also underwent total hip replacement.  All this while raising three small children.  Treatment of her lymphoma included a chemotherapy regimen of adriamycin, bleomycin, vinblastine and dacarbzin.  Her treatment for thyroid cancer featured radioactive iodine.  Bethany credits oxygen therapy for helping her to become free of thyroid cancer and these maintains her health with levothyroxine.   Bethany cannot tell you exactly when she first detected in the vicinity of her thyroid.  It had been there for years when her mother visited, saw the lump and insisted she seek medical attention.  This led to a series of scans and the discovery of a second lump near her clavicle.  A biopsy of the lump on her collarbone resulted in a diagnosis of Hodgkin lymphoma in the Autumn of 2022, while the biopsy of the lump on her thyroid came back as "indeterminant."  Bethany's care team said it would turn its attention to the thyroid lump after addressing her lymphoma diagnosis.   She was placed on a six-month regimen of ABVD chemotherapy, which included adriamycin, bleomycin, vinblastine and dacarbazine.  Bethany suffered many of the usual side effects tied to chemo, including fatigue, nausea and hair loss.  The latter forced her to cut her hair short and then the purchase of a half dozen wigs of different colors.    Bethany attained survivorship from Hodgkin lymphoma, but halfway through her chemo, she underwent a PET scan, which showed two lesions, one on her C5 vertebrae and one on hip.  She underwent a biopsy on the lump on her thyroid in the Spring of 2023, which not only indicated follicular thyroid cancer, but that it had metastasized to the bones in her vertebrae and right hip.    Bethany had to undergo a thyroidectomy and because was eating away at her right hip, it, too, had to be removed.   In September 2023, she began a three-dose regimen of radioactive iodine, which forced her to be kept in isolation.  She was given another CT scan that revealed that cancer was in twelve places in her bones.   Bethany said the pain of her hip replacement exceeded that of three times giving birth without painkillers.  She says she is able to walk just fine these days, walking that includes her love for hiking, and her lack of a thyroid is successfully addressed with levothyroxine, which replaces the hormones lost when her thyroid was removed.   Bethany Smith has experienced the physical toll of her two cancer journeys, but then and now, she deals with everything that has come her way with her natural and boundless sense of optimism.   Additional Resources:   Bethany's app: https://www.stillcancercompanion.com   Bethany's YouTube channel: Bethany Smith Cancer          

Die Angst vor dem Autofahren war bei Mara so groß, dass sie lange behauptete, gar keinen Führerschein zu haben. Häufig sind diese Ängste irrational, sagt eine Verkehrspsychologin. Eine Fahrlehrerin, die hilft, die Angst zu überwinden, gibt Tipps.**********Ihr hört: Gesprächspartnerin: Mara, hat acht Jahre lang verschwiegen, dass sie einen Führerschein hat, weil sie Angst vor dem Autofahren hatte Gesprächspartner: Ulrich Chiellino, Verkehrspsychologe beim ADAC Gesprächspartnerin: Silvia Wirtz, Fahrlehrerin, gibt Auffrischungskurse für Frauen, die Angst vor dem Autofahren haben Autor und Host: Przemek Żuk Redaktion: Sarah Brendel, Yevgeniya Shcherbakova, Friederike Seeger, Till Tognino Produktion: Philipp Adelmann**********Quellen:Fischer, C., Schröder, A. & Heider, J. (2021). Kognitive Verhaltenstherapie bei Autofahrangst. Psychotherapeut, 66, 132–139.Fischer, C., Heider, J., Schröder, A. et al. (2020). “Help! I'm Afraid of Driving!” Review of Driving Fear and its Treatment. Cognitive Therapy and Research, 44, 420–444.Becker, E. S., Rinck, M., Türke, V., et al. (2007). Epidemiology of specific phobia subtypes: Findings from the Dresden Mental Health Study. European Psychiatry, 22(2), 69–74.Fischer, C., & Heider, J. (2024). Angstfrei Auto fahren: Ein kognitiv-verhaltenstherapeutisches Behandlungsmanual. Deutscher Psychologen Verlag, Berlin. ISBN 978-3-942761-84-0. Heider, J., Fischer, C., & Schröder, A. (2018). Die deutsche Version des “Driving Cognitions Questionnaire” (DCQ). Zeitschrift für Klinische Psychologie und Psychotherapie, 47, 36–47. **********Mehr zum Thema bei Deutschlandfunk Nova: Autofahren: Wenn wir am Steuer Angst bekommenRekord bei Pkw-Zulassung – Mobilitätsforscher Andreas Knie: "Es sind weniger mehr Autos"Verkehrswende: Wieso Menschen auf dem Land lieber mit dem Auto fahren**********Den Artikel zum Stück findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .**********Meldet euch!Ihr könnt das Team von Facts & Feelings über Whatsapp erreichen.Uns interessiert: Was beschäftigt euch? Habt ihr ein Thema, über das wir unbedingt in der Sendung und im Podcast sprechen sollen?Schickt uns eine Sprachnachricht oder schreibt uns per 0160-91360852 oder an factsundfeelings@deutschlandradio.de.Wichtig: Wenn ihr diese Nummer speichert und uns eine Nachricht schickt, akzeptiert ihr unsere Regeln zum Datenschutz und bei Whatsapp die Datenschutzrichtlinien von Whatsapp.

Respiratory failure occurs when the respiratory system can no longer adequately meet the oxygen demands of the body, remove carbon dioxide effectively, or both. In this episode you'll learn: - Types and causes of respiratory failure - Signs & symptoms of respiratory failure - Tests used to evaluate respiratory failure - Treatments for hypoxemic respiratory failure and hypercapnic respiratory failure. Read the article "A Quick Guide to Respiratory Failure for Nursing Students" here. Review how to conduct a respiratory assessment in episode #237. Nursing School Survival Blueprint - Feeling overwhelmed or unsure how to approach nursing school? Download this free Blueprint to understand exactly what's working against you — and what to do instead.

Covid and the banality of evil. Most people assumed Tony Fauci was either a brilliant scientist or an evil mastermind, or maybe both. His diary reveals he's just a vain teenage girl pining for cable news hits. Mary Talley Bowden, MD, is a Houston-based, Stanford-trained otolaryngologist. During the COVID-19 pandemic she became a prominent advocate for early outpatient treatments and greater healthcare transparency, positions that placed her in open conflict with major medical institutions. She is the author of Dangerous Misinformation: The Virus, the Treatments, and the Lies. Paid partnerships with:Angel Studios: Watch the Charlie Kirk Documentary at http://angel.com/carlson American Financing: NMLS 182334, nmlsconsumeraccess.org. APR for rates in the 5s start at 6.327% for well qualified borrowers. Call 800-685-5696 for details about credit costs and terms. Visit http://www.AmericanFinancing.net/Tucker. Mars Men: For a limited time, our listeners get 50% off FOR LIFE, free shipping, AND 3 free gifts at Mars Men at MenGoToMars.comTCN: Watch ‘The World Is Watching You' only on https://tuckercarlson.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to this week's Midlife Minute. This episode is dedicated to the overwhelming number of HRT-related questions I've received from my community in 2026. Hormone replacement therapy has generated more questions than almost any other midlife topic, especially regarding timing, progesterone, testing, and special situations. IN THIS EPISODE, YOU WILL LEARN: Women can still benefit from HRT later in menopause. The importance of working with a knowledgeable prescriber when making hormone replacement therapy decisions How progesterone tolerance can vary from one woman to another Why your blood work should be timed according to when you apply your estradiol patch, and why I prefer to focus on estradiol rather than routinely monitoring progesterone levels How the synthetic hormones used in oral contraceptives differ from the bioidentical hormones used in HRT How your medical history can influence your hormone replacement therapy plan Fear and outdated information may continue to create confusion about hormone replacement therapy. Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line

In this episode, we explore the OPTIMUM trial, a landmark study examining how to treat older adults with treatment-resistant depression when antidepressants fall short. When adding a medication outperforms switching entirely — and what that means for the patient sitting across from you — the answer may reshape your clinical approach. Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 83 Antidepressant Augmentation vs. Switching in Geriatric Depression: Key Findings from the OPTIMUM Trial

Are surgical risks in EDS exaggerated, underestimated, or simply misunderstood? And how can patients tell the difference between a promising treatment and an expensive procedure being marketed ahead of the evidence? In this listener Q&A episode, host Dr. Linda Bluestein, the Hypermobility MD, is joined by recurring co-host Dr. Dacre Knight, Medical Director of the UVA Health EDS and Hypermobility Disorders Center, to tackle some of the most difficult questions submitted by the Bendy Bodies community. They begin with a candid discussion about surgery in EDS: why most patients do well, which complications are genuinely more likely, and why a surgeon's technical experience and procedural volume may matter just as much as their understanding of EDS (Ehlers-Danlos Syndromes) and HSD (Hypermobility Spectrum Disorders). They also explain how poorly controlled mast cell activation can derail recovery and why preparation before surgery may be more important than simply being reassured that everything will be fine. The conversation then turns to the striking mental health burden within the EDS and hypermobility population, including self-harm and cutting behaviors. Dr. Bluestein and Dr. Knight discuss why anxiety, depression, insomnia, and pain may sometimes reflect shared underlying biological drivers, and how treatments such as low dose naltrexone (LDN) may improve multiple symptoms at once when used thoughtfully. Listener questions lead them into the increasingly controversial world of cervical instability treatment, including PRP, the PICL procedure, and cervical fusion. What evidence actually exists? Who may benefit? What are the risks? And could treating mast cell activation and other contributors first reduce symptoms enough to avoid an invasive procedure altogether? They also take a critical look at IV infusion therapy, explaining when infusions may be medically appropriate, when they may cause more harm than benefit, and why clinics offering the same expensive infusion to nearly every patient before reviewing labs should immediately raise concern. The episode closes with an honest assessment of what is currently known about the cause of hypermobile EDS (hEDS), whether epigenetics may play a role, and why patients should pause whenever a clinician recommends a highly prescriptive treatment before completing a proper diagnostic evaluation. Takeaways: EDS surgery risks are real, but fear-based messaging can be harmful too. Most patients do well, especially when they choose an experienced, high-volume surgeon and address factors such as mast cell activation syndrome (MCAS) before the procedure. A kind surgeon is not necessarily a skilled surgeon. Bedside manner matters, but technical expertise, procedural volume, complication rates, and careful postoperative planning may matter even more. Mental health symptoms in EDS should not automatically be dismissed as “just anxiety.” Pain, poor sleep, mast cell activation, autonomic dysfunction, inflammation, and other biological drivers can profoundly affect emotional health and may need to be treated alongside psychological support. One treatment can sometimes improve far more than one symptom. When appropriately prescribed, low dose naltrexone (LDN) may improve pain, sleep, mood, anxiety, GI symptoms, and overall function by addressing shared underlying mechanisms. PRP and the PICL procedure are promising options for carefully selected patients, particularly given the significant risks and irreversible nature of cervical fusion. While early experience is encouraging, we still need higher-quality studies to better define who benefits most, what the long-term outcomes are, and how these procedures compare with other treatment options. Go http://www.AquaTru.com now for 20% off (your purifier) using promo code BENDY. Want to learn more about the UVA EDS Center? For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Sam Ashoo, MD and Dr. T.R. Eckler, MD discuss the July 2026 Emergency Medicine Practice article, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management in the Emergency Department.0:17 – Intro & sponsor promo1:09 – Episode introduction4:03 – Definitions: SJS vs. TEN vs. "overlap" by body surface area6:12 – Pathophysiology9:52 – Incidence and rarity of the disease10:53 – Differential diagnosis & clinical presentation clues12:08 – Prehospital care & fluid resuscitation considerations13:47 – ED history-taking: medications, infections, rash progression14:47 – Physical exam findings16:46 – Diagnostic studies18:12 – Scoring systems: SCORTEN and ABCD-1020:50 – Treatment goals23:57 – Wound care principles24:43 – Mechanical ventilation risk factors26:02 – Other possible therapies27:50 – Specialty consults & special populations29:06 – Ophthalmologic treatment31:17 – HIV patients and elevated risk31:55 – Emerging therapies & AI-based diagnostic tools32:57 – Five key clinical takeaways34:37 – Closing remarks & sponsor sign-offSubscribers, take the CME test here.Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

ArticlesComparison of Functional Outcomes and Safety of Acute Carotid Stent Placement versus Thrombectomy Alone in the Treatment of Patients with Tandem Occlusions in Acute Ischemic Stroke (Read)Portal Vein Stent Placement in a Pancreatic Cancer Cohort: Outcomes and Predictors of Portal Stent Occlusion (Read)Stereotactic Percutaneous Thermal Ablation of Primary and Metastatic LiverTumors: A Prospective Registry-Based Study (Read)HostMarie Hamel, the Warren Alpert Medical School of Brown UniversityAudio editorAndrew Sasser, University of Miami Leonard M. Miller School of MedicineAbstract readersDonald Chow, Saint Louis University School of MedicineEvan Massa, Philadelphia College of Osteopathic MedicineSara Sadok, University of Illinois College of Medicine - ChicagoSupport the show

There are medical doctors, osteopathic doctors and naturopathic doctors. You don't hear as much about the NDs but they are a part of the healthcare system. The question is, can they help or assist you if you have an anxiety condition? In this episode, a look at the licensed naturopathic doctors, the services offered and can they be another healthcare resource? Resources Mentioned:  The U.S. National Institute of Health has an explainer page about Naturopathic Medicine.   The Council on Naturopath Medical Education has an information page on the type of conditions these doctors treat.   American Association of Naturopathic Physicians has a map that shows where naturopathic doctors are licensed in the U.S. and Canada and the current status of other U.S. states considering licensing these types of doctors.   Emergency Resources   The Trevor Project: Provides crisis support specifically for LGBTQ+ youth through phone (1-866-488-7386), text (START to 678-678), and online chat. Available 24/7. They also provide peer support and community.    Veterans Crisis Line: Call 988 and press 1, text 838255, or chat online. There are phone lines for those serving overseas. Visit the website to find the current status of the Veteran line and international calling options.    National Crisis Text Line: Text HOME to 741741 for free, confidential support 24/7. This service operates independently of the 988 service. Users can use text, chat or WhatsApp as a means of contact.   Disclaimer:  Links to other sites are provided for information purposes only and do not constitute endorsements.  Always seek the advice of a qualified health provider with questions you may have regarding a medical or mental health disorder. This blog and podcast is intended for informational and educational purposes only. Nothing in this program is intended to be a substitute for professional psychological, psychiatric or medical advice, diagnosis, or treatment.

Are you treating extrapulmonary neuroendocrine carcinomas based on where they start—or what they actually are? In this faculty follow-up to their i3 Health activity (Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets), Andrew Hendifar, MD, and Danielle Hutchings, MD (Cedars-Sinai Medical Center), unpack why treating these rare, aggressive tumors according to site of origin rather than tumor lineage can compromise outcomes. They clarify crucial pathologic distinctions between well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) while emphasizing the essential role of multidisciplinary collaboration in precision care. The experts also explore the novel therapeutic landscape of delta-like ligand 3 (DLL3)–targeted therapies, highlighting the promise of DLL3 T-cell engagers in extrapulmonary disease. They address ongoing diagnostic hurdles—such as standardized immunohistochemistry (IHC) expression thresholds and expanding send-out testing access—while sharing key insights on emerging clinical trials evaluating T-cell engager monotherapies and chemo-immunotherapy combinations. Claim your CME credit: bit.ly/488fPhK Download and review the companion Clinical Challenges in Extrapulmonary NEC Slide Deck: bit.ly/4w2Pni3

A significant response operation has been completed at Glenbeigh Wastewater Treatment Plant. Specialist operational and environmental teams and contractors have decontaminated the site and returned the plant to normal operations after a contaminate dot into the system. Jerry spoke to Ronán O'Shea of Uisce Éireann.

Truth Be Told with Booker Scott – Thousands of vaccine-injured Americans seek recognition, compassionate care, and effective treatment as independent doctors gather evidence, develop protocols, and pursue clinical trials. The growing effort challenges medical denial, demands accountability, and insists that informed consent and honest investigation remain essential to patient-centered medicine and healing...

HEALTH NEWS   Review finds blueberry and grape polyphenols may improve vascular health Plant compound shows promise for treating rheumatoid arthritis at its source, study finds Screen Time at Ages 1 and 6 Linked to Lasting Learning and Memory Effects Some caffeinated drinks are linked to poorer memory Study: Morning Exercise Linked to Lower Daily Calorie Intake Compared to Evening Workouts   Review finds blueberry and grape polyphenols may improve vascular health Universidad Católica de Murcia (Spain), July 27 2026 (News-Medical) A recent review published in the journal Nutrients examined the evidence on the effects of blueberries, grapes, and their bioactive compounds on cardiovascular risk markers. In the present study, a comprehensive systematic literature search was conducted to identify randomized controlled trials (RCTs), systematic reviews, and meta-analyses published from January 2015 through April 2026.  Two systematic reviews and meta-analyses reported that grape polyphenols at doses exceeding 500 mg/day for at least 12 weeks significantly reduced C-reactive protein levels, while the other reported improvements in vascular function or BP in 84% of the human studies it assessed, including a significant reduction in systolic BP. One found a modest reduction in BP and improvement in endothelial function with flavan-3-ol foods, such as tea, apples, cocoa, and grape-derived products. Moderate- and high-quality RCTs reported improvements in lipid peroxidation, lipid profiles, flow-mediated dilation, diastolic BP, and paraoxonase activity. Resveratrol and blueberry RCTs mainly reported endothelial and vascular benefits, such as improved nitric oxide production and flow-mediated dilation and reduced BP and inflammatory markers. One high-quality RCT involving older men with metabolic syndrome showed significant improvements in arterial stiffness and endothelial function after six months of daily blueberry consumption.     Plant compound shows promise for treating rheumatoid arthritis at its source, study finds Guangzhou University of Chinese Medicine, July 27 2026 (Natural News) A plant-derived compound called obakulactone (OL) reduced swelling, inflammation and joint damage in rats with rheumatoid arthritis, according to a study published in Engineering.   The compound, a tetracyclic triterpenoid from the bark of Phellodendri cortex, also rebalanced immune activity and corrected disrupted fatty acid metabolismd. P. cortex has been used in traditional medicine and contains OL along with other constituents, Researchers tested OL in rats with rheumatoid arthritis, administering low, medium and high doses for 21 days. Treatment significantly reduced joint swelling and helped restore the normal structure of cartilage and the synovium, the tissue lining the joints, according to the report.   Blood tests showed dose-dependent decreases in inflammatory molecules including IL-1, IL-6, IL-17 and TNF, as well as rheumatoid arthritis markers RF, CCP-Ab, CRP and MMP-3, officials said. The compound also reduced abnormally high levels of CD3+ T cells and CD68+ macrophages within the joints and shifted macrophages from a proinflammatory M1 state toward an anti-inflammatory M2 state.   Screen Time at Ages 1 and 6 Linked to Lasting Learning and Memory Effects National University of Singapore & Zhejiang University (China), July 28, 2026 (SciTech Daily) A study that tracked children from age 1 through age 8 found that greater screen viewing time, especially during infancy and near the start of school, was associated with lower academic performance at age 9 and weaker working memory at age 10.5. The results indicate that when children use screens may matter as much as how long they spend using them. The World Health Organization (WHO) and the American Academy of Pediatrics advise avoiding screens before 18 to 24 months and limiting viewing to less than one hour per day between ages 2 and 5. Many children exceed those recommendations, yet previous research on screens and cognitive development has produced inconsistent results. The analysis included 502 children followed from infancy into middle childhood. Higher screen viewing during particular stages was associated with poorer academic results and weaker working memory later on. The clearest and most consistent relationships appeared during infancy and near school entry, suggesting that these may be especially sensitive periods for cognitive development. Children with greater total screen exposure across childhood also generally performed less well in school. Together, the findings suggest that both the timing and overall amount of viewing may have implications for learning and memory.   Some caffeinated drinks are linked to poorer memory Applied Science Private University (Jordan), July 28 2026 (News-Medical) A recent study in the Journal of Education and Health Promotion examined the association between caffeine-containing products and memory performance, anxiety, and stress among university students in Jordan. 204 students were ultimately included in the study.  Mild psychological distress was the most common category, with 38.2% reporting such symptoms. About four in ten reported mild depression, and over a quarter experienced moderate anxiety. Only a small minority showed severe or extremely severe stress. Caramel or nut-filled chocolate was the most frequently consumed item, reported by 54.9% of students, followed by Arabic coffee (40.2%) and red tea (35.8%). Milk chocolate was also popular, typically consumed once or twice a day. Dark chocolate was less common, while American coffee and green tea were less popular, and decaffeinated coffee was rarely chosen. Overall DASS scores, representing depression, anxiety, and stress symptoms, showed positive correlations with the consumption of dark chocolate, American/instant coffee, decaffeinated coffee, and red tea, indicating these items were linked to higher psychological distress scores. Memory ability was negatively associated with higher intake of American coffee, Arabic coffee, and soft drinks.  The authors note that chocolate and green tea also contain bioactive compounds such as cocoa flavanols and L-theanine, which may have contributed to these associations alongside caffeine.   Study: Morning Exercise Linked to Lower Daily Calorie Intake Compared to Evening Workouts Copenhagen University Hospital (Denmark), July 27 2026 (Natural News)   A new study has found that morning exercise was associated with lower calorie consumption throughout the day compared to evening workouts, according to the research. Participants who exercised in the morning consumed about 400 fewer calories at the post-workout meal and roughly 547 fewer calories over the full 24-hour period, the study reported.   The study, which involved 35 healthy young adults. Each participant completed 30 minutes of treadmill running multiple times under varying conditions: morning fasted, evening fasted for 12 hours or 6 hours, and morning or evening fed, the study stated. The repeated-measures design enabled researchers to compare the same person's responses across different scenarios, officials said. After evening sessions, participants reported higher hunger, a stronger desire to eat, and lower fullness compared to morning sessions, the study found. Those who worked out in the evening consumed about 400 more calories at the post-workout meal and roughly 547 more calories over the full day, according to the research.   The appetite advantage was attributed to circadian rhythms, researchers said. The hunger hormone ghrelin naturally rises in the evening, while satiety hormones are more active in the morning,.

Welcome to The Times of Israel's Daily Briefing, your 20-minute audio update on what's happening in Israel, the Middle East and the Jewish world. US bureau chief Jacob Magid joins host Amanda Borschel-Dan for today's episode. Yesterday, Prime Minister Benjamin Netanyahu visited the White House for his first in-person talks with US President Donald Trump since the Iran war began in February. Closed to the press, later statements about the meeting were laconic, with Israel describing it as “excellent” and “one of the best we’ve ever had,” and the White House calling the talks productive and positive. Magid reviews what we know about the meetup and hypothesizes why the long-awaited talks were held in such an atypically subdued fashion. We hear about overnight flare-ups in the Iran conflict after the regime targeted US forces in Jordan and the US and Saudi Arabia launched deadly strikes on Tehran-backed militias in Iraq, blaming them for drone attacks on Saudi oil facilities. How close were the sides to resuming the memorandum of understanding -- and what may happen now? Securing Saudi Arabia is the focus of our final item as well: Magid brings exclusive reporting on how Pakistani military chief Asim Munir leveraged a joint oil transport venture with Islamic Revolutionary Guard Corps chief Ahmad Vahidi to secure an agreement between Iran and Saudi Arabia under which Tehran agreed to halt attacks against the Gulf kingdom. Check out The Times of Israel's ongoing liveblog for more updates. For further reading: Netanyahu: Meeting with Trump was one of our best ever; White House: Productive, positive Wary of perception that Israel driving war, Trump and Netanyahu opt to avoid optics altogether ‘He loved Israel’: Lindsey Graham eulogized by Trump and other dignitaries at DC funeral US-Saudi strikes target Iraqi pro-Iran militias as IRGC renews attacks on US forces Pakistan army chief leveraged private oil venture with IRGC head to shield Saudi Arabia Subscribe to The Times of Israel Daily Briefing on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. This episode was produced by Ari Schlacht.See omnystudio.com/listener for privacy information.

Send us Fan MailThis week on Translational Conversations, we talk with Dr. Zoe Donaldson, a prairie vole researcher, and Dr. Katherine Shear, a human researcher, about how their work has inspired and influenced each other's research on attachment bonding, love and loss, and the development of Prolonged Grief Disorder. In this episode, Dr. Donaldson and Dr. Shear discuss the role of the brain's reward system in grief, how grief differs from depression, the special bonding of prairie voles that makes them an ideal species for studying grief, and how their complementary research has inspired novel treatments for Prolonged Grief Disorder. Their discussion further explores the bidirectional process of translational research, how to consider the language we use when communicating findings from different species, and ways we can build better bonds between researchers to advance scientific progress. We thank Dr. Zoe Donaldson, the Larry Gold Professor in the Department of Molecular, Cellular, and Developmental Biology and the Department of Psychology and Neuroscience at the University of Colorado Boulder and Dr. Katherine Shear, the Marion E. Kenworthy Professor of Psychiatry at Columbia University and the founding Director of the Center for Prolonged Grief at Columbia School of Social Work, for their openness and willingness in discussing their research with us for this podcast.Translational Conversations is made possible through support from Biomedical Research Awareness Day, a program of Americans for Medical Progress and the American College of Neuropsychopharmacology.Resources & Links: Craving Love? Enduring grief activates brain's reward center by Mary-Frances O'ConnorNeurobiology and treatment advances for prolonged grief disorder by Donaldson and ShearPrairie Voles as a model of adaptive reward remodeling following loss of a bonded partner by Sadino and Donaldson Support the showFollow Lab Rat Chat on X! Facebook! Instagram!https://twitter.com/thelabratchat https://www.facebook.com/labratchat https://www.instagram.com/thelabratchat All Lab Rat Chat episodes are edited by Audionauts: https://audionauts.pro/ 

Marianne Apostolides is the award-winning author of eight books, four of which have been translated and published internationally. She is a two-time recipient of the Chalmers Arts Fellowship and winner of the K.M. Hunter Award for Literature. Her books include I Can't Get You Out of My Mind, Deep Salt Water, Voluptuous Pleasure: The Truth about the Writing Life, and Swim. Moving across fiction, memoir, and literary nonfiction, her work often returns to the body, desire, memory, and the stories we tell about ourselves. Her latest book is Go/No-Go: A Journey Into the Research and Treatment of Mental Health Disorders, which has been called "required reading for anyone with a stake in mental health care." Marianne has described the book as beginning in 2022, during a period of creative and emotional crisis, when she encountered a research article that changed how she understood the human mind. In the prologue, she writes that we have "reached a dead end" in our current approach to mental health disorders. The book traces how we arrived there and where we might turn instead. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

Polycystic ovary syndrome has long been associated mainly with irregular periods, ovarian cysts and fertility concerns. But the condition can also affect insulin resistance, weight, heart health, diabetes risk and other systems throughout the body—one reason the new name PMOS, or polyendocrine metabolic ovarian syndrome, is gaining attention.Host Sandra Peebles talks with Baptist Health endocrinologist Dr. Priscilla Escalona Villasmil and obstetrician-gynecologist Dr. Ingrid Paredes about what the name change means, how PMOS is diagnosed and why symptoms can look very different from one woman to another.In this episode: Why the condition is about much more than ovarian cysts  Common signs, including irregular periods, acne, excess hair growth and hair loss  How doctors diagnose PMOS and rule out other hormonal conditions  What PMOS means for ovulation, fertility and unplanned pregnancy  The connection to insulin resistance, diabetes and cardiovascular risk  Treatment options, including lifestyle changes, birth control pills, metformin, spironolactone and GLP-1 medications  Why early diagnosis and coordinated care can improve long-term health PMOS is manageable, and a diagnosis does not mean pregnancy is impossible. Early evaluation by an OB-GYN and an endocrinologist can help patients address both reproductive and metabolic health.Host:Sandra PeeblesAward-Winning JournalistGuests:Ingrid Paredes, M.D. Obstetrician/GynecologistPriscilla Escalona Villasmil, M.D.Endocrinologist Baptist Health

Dr. Don and Professor Ben talk about the risks from drinking water from a source that failed to maintain treatment for removing bacteria. Dr. Don - not risky

Dangerous Misinformation: The Virus, the Treatments, and the Lies by Dr. Mary Talley Bowden MD https://amzn.to/4gWN0tc   Learn more about and follow Dr. Mary Bowden: https://x.com/MaryBowdenMD https://substack.com/@marybowdenmd  

Host Branden Hudson interviews longtime friend Jessica Burke, owner of Atlantic Recovery in Salisbury, Maryland, an outpatient medication-assisted treatment clinic opened February 1, 2018. Burke shares how her own progression from alcohol addiction (including DUIs, jail, and court-ordered IOP) to prescription opioid addiction led her to seek treatment and build a reliable, local program that lets patients maintain work and family life while receiving medications such as Suboxone, Zubsolv, Subutex, and Vivitrol, plus required one-on-one counseling and regular urine screens with visits tapering from weekly to monthly. They discuss withdrawal as a major barrier to recovery, respond to stigma that MAT is “legal drug dealing,” and emphasize individualized levels of care, boundaries vs enabling for families, and that addiction affects all walks of life. Burke provides Atlantic Recovery's location, website/socials, and notes calls route to her directly.00:00 Welcome And Housekeeping00:57 Meet Jessie Burke02:01 Atlantic Recovery Overview02:35 Why She Started03:15 What Makes It Different04:53 How Outpatient MAT Works09:56 From Alcohol To Opiates10:47 How Addiction Escalates13:40 Close Calls And Justifying18:26 Quitting Alcohol For Good21:15 Host Shares Sober Journey25:28 Sober Life Wins26:43 Suboxone Stigma Debate30:04 Withdrawal Reality Check32:06 Treatment Beyond Medication33:30 Clinic Challenges and Growth37:16 Advice for Parents41:12 Losses and Boundaries44:17 Future Vision and Politics47:56 Where to Get Help49:30 Final Message and Wrap

In this podcast episode, Natalie S. Callander, MD, and Tom Martin, MD, discuss the optimal approaches for the determination of whether a patient with high-risk SMM requires treatment or observation, including: Contemporary Risk Stratification Interpreting Evidence for Early Intervention Treatment vs Observation: Patient Selection Treatment Selection and Sequencing Considerations Safety, Monitoring, and Supportive Care Implementation in Practice Shared Decision-making and Patient Communication Emerging Therapies and Clinical Trials Presenters:  Natalie S. Callander, MD Professor of Medicine Director, Myeloma Clinical and  Cellular Therapy Program University of Wisconsin Carbone  Cancer Center Madison, Wisconsin Tom Martin, MD Professor of Medicine Associate Chief, Hematology/Oncology UCSF Medical Center San Francisco, California Link to full program:https://bit.ly/4wqpYzU Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

** Want more? Become a part of my community! Sign up for Zibby's Highlights, which includes a free weekly newsletter, event livestreams, most anticipated book lists, personal essays, and a new essay platform with stories from all of you about what chapters you're in (inspired by my upcoming book Between Chapters: How I Started Over, Took Some Chances, and Found the Plot, 9/22/26). And follow me on Instagram @zibbyowens. But really, keep listening here. If you love my show, please tell a friend! Hosted on Acast. See acast.com/privacy for more information.

Puberty doesn't always follow the expected timeline. What happens when it shows up ahead of schedule? For pediatricians, the early appearance of breast development, pubic hair or accelerated growth can trigger a cascade of questions. Is this a normal variant? Should we investigate further? When is it time to refer? In this episode, we unpack the complexities of precocious puberty and explore how timely identification and thoughtful management can make a lasting difference for kids and their families.  To create clarity, we are joined by Stephanie Hsu, MD, PhD, and Clare Parker, MD. Dr. Hsu specializes in endocrinology here at Children's Hospital Colorado and is an associate professor at the University of Colorado School of Medicine. Dr. Parker is a pediatric endocrinology fellow. Some highlights from this episode include: The differences in early puberty between boys and girls  Environmental impacts that can lead to misleading results  Signs and symptoms pediatricians can look out for  Treatment options and their severity  For more information on Children's Colorado, visit: childrenscolorado.org. 

Is Medication Right for Your OCD? A Psychiatrist Breaks Down SSRIs, Dosing, and What Actually WorksIf you've ever wondered whether medication could help your OCD or anxiety, or you've tried an SSRI and felt like "nothing worked," this episode is for you. Matt Codde, LCSW sits down with Dr. Melissa Quinn, a triple board certified psychiatrist who specializes in OCD treatment, for a full breakdown of how medication actually works, why so many people are underdosed, and how medication and therapy work together rather than against each other.Dr. Quinn walks through SSRIs, clomipramine, augmentation strategies, and common myths (including the cannabis conversation you don't want to miss), while Matt reframes ERP through the Restored Minds lens of emotional integration rather than symptom elimination.

https://holplus.co/appointments Are we over-treating breast cancer? Learn why metabolic dysfunction may be the real driver behind many diagnoses and how to rethink treatment.Approximately 20 to 30 percent of screen detected breast cancer cases are treated unnecessarily. This video challenges the current standard of breast cancer treatment by focusing on the underlying metabolic health factors that often go unaddressed. If you are concerned about the current approach to screening or are looking for a more preventative perspective, this discussion provides a critical look at how we diagnose and manage the disease.We break down the three major drivers that contribute to long-standing metabolic dysfunction. By identifying these root causes, we can move toward a more accurate breast cancer diagnosis and more effective, targeted strategies for long-term health.Subscribe for weekly health and metabolic disease breakdowns, and comment below with your thoughts on these new findings.If you are navigating cancer treatment or recovery, concerned about inflammation, or want personalized support for your hormones and nutrition, explore related Hol+ care options here:Cancer Support:https://holplus.co/services/cancer-support/Inflammation:https://holplus.co/conditions/inflammation/Hormone Balancing:https://holplus.co/services/hormone-balancing/0:00 Rethinking Breast Cancer Care1:04 Meet Dr. Jen Simmons2:59 A Family History of Cancer6:53 When the Doctor Becomes the Patient12:53 Why We Focus on the Wrong Thing18:51 Navigating a Diagnosis23:24 The Flaws in Mammographic Screening35:17 A New Paradigm for Breast Health*About Dr. Jenn Simmons:*Dr. Jenn Simmons is an Integrative Oncologist, Breast Surgeon, Author, Podcast Host, and the founder of PerfeQTion Imaging. Her journey into breast cancer care began with a personal tragedy. At the age of 16, Dr. Jenn's cousin, acclaimed singer-songwriter Linda Creed, died of metastatic breast cancer just weeks after Whitney Houston's recording of her iconic song, "The Greatest Love of All," topped the charts. This loss became a defining moment, inspiring Dr. Jenn to dedicate her life to transforming how we approach breast cancer treatment and prevention.Dr. Jenn became Philadelphia's first fellowship-trained breast surgeon and spent 17 years leading the field. However, her perspective changed significantly when she became a patient herself. Through this personal experience, Dr. Jenn saw how broken the conventional medical system can be. This led her to discover and embrace functional medicine, a revelation that sparked her journey towards a more holistic approach to breast cancer care.Connect with Dr. Jenn Simmons:https://www.realhealthmd.com/https://www.instagram.com/drjennsimmons/https://www.youtube.com/@dr.jennsimmonsAbout Dr. Taz:Dr. Tasneem Bhatia (Dr. Taz) is a triple board-certified integrative medicine physician,bestselling author, and founder of hol+ a multi-location integrative medicine practice.Learn more: https://doctortaz.com/aboutStay Connected:Connect further to Hol+ at https://holplus.co/ - Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.Book a Hol+ Consultation: https://holplus.co/locations/virtual/Follow Dr. Taz on Instagram:https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Subscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsProduced by https://ClipGrowth.com (Producer: Pat Gostek)

In this episode, Jackie Powers, MD, MS, FAAP, discusses the prevention and treatment of iron deficiency in infants, children and adolescents. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Daniel Smolyak, PhD, about built environmental factors linked to fatal motor vehicle collisions among U.S. children. For resources go to aap.org/podcast.

Tongue-tie releases have become more common than ever—but does every tongue-tie actually need to be released? In this episode, I share why my answer might surprise you. Instead of focusing on the procedure itself, I explain why the most important question to ask first is much simpler: Can you breathe through your nose? I walk you through the complete evaluation process I use before ever recommending a tongue-tie release, why myofunctional therapy is an essential part of treatment, and how breathing, posture, airway health, nervous system regulation, jaw function, and even body compensation all play a role. Whether you're a parent, an adult considering treatment, or a healthcare provider, this episode will help you better understand why the best outcomes come from treating the whole person—not just the tongue. If you enjoyed this episode, I'd love for you to follow the podcast, leave a rating and review, and share it with someone who could benefit from this conversation. Your support helps more people discover the Healthy Mouth Movement Podcast, and I truly appreciate you being part of this community. See you in the next episode! Check out The Mind Mouth Body SHIFT Method -- https://shereewertz.com/academy Book a consultation today: I am always here to help answer any question and schedule a 15 minute call with me. If I can not help, I can get you to a provider that can. https://shereewertz.com/15-min

Denise Salem, Oncology Chaplain at Riverside Healthcare, explains how pastoral care adds an extra layer of support alongside medical treatment by providing a listening presence, spiritual resources when wanted, and practical help for families and staff. She describes outpatient chaplain visits at the Riverside Cancer Institute and infusion clinics in Bourbonnais, Watseka, Frankfort, and Coal City; the non‑proselytizing, faith‑inclusive nature of chaplaincy; and common issues addressed—including fear of the unknown, guilt, loneliness, and the modern problem of “cancer ghosting.” Salem shares examples of how caregivers and friends can show up—daily texts, group devotions, or small creative gestures—how chaplains help patients identify reasons to hope (trusted medical teams, future milestones), and why adaptability and meeting patients where they are are central to effective pastoral care.

Should you go natural or conventional? Dr. Pai explains how to combine treatments based on labs, cancer type, and risk—plus avoid unnecessary therapies. #IntegrativeOncology #CancerCare #SmartMedicine

Listen in to learn from Thomas Bachelot, MD, PhD, and Mafalda Oliveira, MD, PhD, about recent advances and the integration of anti-TROP2 antibody-drug conjugates (ADCs) into the management of patients with triple-negative breast cancer, including as first-line therapy for those who are not eligible for immunotherapy. Experts will cover: The evolving role of TROP2-directed antibody-drug conjugates (ADCs), including sacituzumab govitecan and datopotamab deruxtecan, in addressing unmet needs in the frontline treatment of TNBC.  Treatment sequencing, reimbursement barriers to recent approvals, and toxicity-informed treatment selection considerations. How to monitor and manage ocular and pulmonary toxicities and care-team readiness for implementing ADC-based therapy in routine practice. Presenters:Thomas Bachelot, MD, PhD Medical Oncology Department of Oncology Léon Bérard Center Lyon, France Mafalda Oliveira, MD, PhD Senior Consultant Medical Oncology Department Vall d'Hebron University Hospital Senior Clinical Investigator Breast Cancer Group Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona, Spain Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify. Visit the program page for more content associated with this discussion. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What if the fatigue, brain fog, joint pain, or mysterious symptoms you've been chasing for years weren't caused by stress, aging, or burnout—but by a tick bite you never even noticed? Lyme disease is one of the most misunderstood illnesses in medicine. But Lyme is rarely just one infection—it's often part of a much bigger picture involving co-infections, immune dysfunction, inflammation, gut health, and environmental triggers. In today's episode, I walk through a functional medicine approach to Lyme disease and tick-borne illness, including: Why Lyme disease is so often missed—and the hidden role of co-infections like Babesia, Bartonella, Ehrlichia, and Anaplasma The limitations of conventional testing and treatment, and how functional medicine looks beyond the infection to understand why some people recover while others remain chronically ill The role of herbs, antibiotics, gut repair, detoxification, immune support, and mitochondrial health in a comprehensive recovery plan What the latest evidence says about emerging therapies like ozone, hyperbaric oxygen therapy, and hyperthermia—as well as practical strategies to prevent tick-borne illness in the first place Lyme disease isn't always just an infection—it's often a whole-body disruption. By addressing the underlying drivers of inflammation, immune dysfunction, gut health, and cellular resilience alongside the infection itself, you give your body the best chance to heal and recover. Resources Mentioned: Track your metabolic health with Function Health: https://functionhealth.com/mark (Use code MARK2026 for $50 off your membership.) Have a question you'd love answered on Office Hours? Submit it here (0:00) Introduction to Lyme disease, overview, and Dr. Hyman's experience (4:13) Functional medicine's approach and comprehensive treatment strategies (10:51) Innovative therapies for Lyme disease (14:08) Managing die-off reactions and restoring gut health (17:18) Supporting the immune and nervous systems; prevention strategies (19:29) Future research, persistent symptoms, and conclusion (21:15) Alzheimer's disease, neuroinflammation, and call to action

Join host Myrna Young as she delves into cancer care and treatments with Dr. Rohit Gosain and Dr. Rahul Gisain, the Oncology Brothers, board-certified hematologists and medical oncologists from New York. This episode explores separating medical facts from media hype, understanding complex cancer research, and addressing treatment disparities. Learn about breakthrough treatments, the importance of personalized medicine, and how informed decisions can impact outcomes. Whether you're a patient, caregiver, or healthcare enthusiast, gain valuable insights into navigating the evolving landscape of cancer care.The Oncology Brothers share their professional journey and why they chose to specialize in oncology and hematology. They discuss how fast-evolving cancer treatments are being communicated and documented at medical conferences and highlight the significance of unbiased perspectives when selecting the best treatment options. Myrna and the doctors also emphasize the importance of understanding screening guidelines and genetic mutations for personalized cancer treatment, discussing various cancer advances like targeted therapies and immunotherapy. This episode serves as an enlightening resource for anyone affected by cancer, offering both hope and practical advice.Key Takeaways:The Oncology Brothers emphasize the explosion of cancer research and development, pointing out the annual approval of new treatments, which brings hope despite the challenges of keeping up with this data.Conferences serve as vital platforms for cancer education, yet the reality of financial and bias conflicts in the healthcare industry necessitates informed and independent patient advocacy.Treatment personalization through genetic profiling and understanding patient-specific mutations are pivotal in tackling cancers more effectively and improving patient outcomes.Listeners are encouraged to seek knowledge on the available cancer treatments, understand screening guidelines, and engage in shared decision-making with healthcare providers for optimal cancer care.Despite disparities in healthcare access due to geographical and financial constraints, efforts are ongoing to make cutting-edge cancer treatments more widely available.Timestamp Summary0:00 Welcome & Introduction2:09 Understanding Cancer Education5:20 Conversations Around Cancer Treatments10:14 The Role of Medical Conferences15:09 Recent Advancements in Cancer Treatment24:39 Patient Advocacy and Treatment Questions31:09 Disparities in Cancer Treatment Access42:31 Closing Remarks and ResourcesResources:OncBrothers WebsiteOncBrothers Podcast on YouTube | Spotify | Apple PodcastsSocial Media: @ONCBrothers on X/TwitterSponsors for this Episode SquareSquare brings payments, POS, inventory, staffing, and online sales together in one system – so business owners don't have to juggle a bunch of tools. Right now, listeners can get up to $200 off Square hardware when you sign up at square.com/go/transformQuinceQuince is not just apparel. Quince also offers elevated essentials for your home, from bedding and bath, to kitchen essentials and furniture.Make your summer wardrobe feel easier. Go to Quince.com/tym for free shipping on your order and 365-day returns Link to Transcript https://www.buzzsprout.com/1761155/19533950-oncology-advances-inside-the-latest-breakthroughs-in-cancer-treatment/transcriptSee this video on The Transform Your Mind YouTube Channel https://www.youtube.com/@MyhelpsUs/videosTo see a transcripts of this audio as well as links to all the advertisers on the show page https://myhelps.us/Follow Transform Your Mind on Instagram https://www.instagram.com/myrnamyoung/Follow Transform Your mind on Facebookhttps://www.facebook.com/profile.php?id=100063738390977Please leave a rating and review on iTunes https://podcasts.apple.com/us/podcast/transform-your-mind/id1144973094Feedspot Top 100 Mental Health Podcast For sponsored Brand interviews and sponsorship inquires please visit Partner With The Transform Your Mind Podcast | Myrna Young Life Coach

Dr. Eugene Lipov is a pioneer of the Stellate Ganglion Block for emotional trauma and mental health challenges and a renowned anesthesiologist with decades of experience. Through his research, Dr. Lipov developed the Dual Sympathetic Reset (DSR), an advanced Stellate Ganglion Block (SGB), proving 80% successful in relief in symptoms of emotional trauma and mental health challenges. His innovative approach and contributions to emotional trauma and mental health challenge treatments have allowed him to help hundreds of patients, including veterans and first responders suffering from PTSD, walk away from treatment with a new perspective on life and the relief they deserve.Heroes Behind HeadlinesExecutive Producer Ralph PezzulloProduced & Engineered by Mike DawsonMusic provided by ExtremeMusic.com

Disability and breast cancer intersect in more than one direction. Some people develop long-term effects like lymphedema, neuropathy or cognitive changes because of treatment — effects recognized as disabilities under the Americans with Disabilities Act. Others are already living with a disability, of any kind, when a breast cancer diagnosis enters the picture. This July, in recognition of Disability Pride Month, Krista Park Berry, Director of Susan G. Komen's Breast Care Helpline, returns to Real Pink to talk about how the Helpline supports people through their breast health experience no matter when their disability started, and what that support looks like for women of color in particular. Key takeaways No two disability experiences are the same Disability can exist before or develop after breast cancer treatment The Komen Breast Care Helpline provides personalized support and resources Accessible, whole-person care improves quality of life and health outcomes Chapters 00:00 – Understanding disability and breast cancer 02:08 – Treatment-related disabilities and ADA protections 06:26 – Supporting people living with metastatic breast cancer 08:11 – Navigating breast cancer with a pre-existing disability 12:11 – Health equity, women of color, and closing care gaps 13:36 – Why asking for help can change everything

In this episode, Nick Stavros, Chief Executive Officer, Community Medical Services, discusses the organization's steady growth, navigating Medicaid and regulatory changes, and the opportunities AI presents for improving care and operations. He also shares his philosophy on servant leadership and empowering teams to drive lasting impact.

In this SRNA “Ask the Expert” episode, GG deFiebre spoke with Dr. Michael Levy and Dr. Benjamin Greenberg about optic neuritis and how it is most often linked to multiple sclerosis but can also be idiopathic or associated with MOGAD and NMOSD. They compared differences across these conditions (including age patterns, bilateral involvement, severity, exam findings, and typical recovery), outlined diagnostic workups such as MRI, antibody testing, and spinal fluid studies, and reviewed acute treatments [03:14]. The discussion also covered emerging therapies like Pivikto for neuroprotection and efgartigimod alfa to lower IgG as a potential alternative to plasma exchange, and examined challenges in remyelination and stem-cell delivery approaches like Q-Cells while cautioning against unproven stem cell clinics [11:57].Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program] at Children's Medical Center. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center. Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients. Michael Levy, MD, PhD is a recognized neurologist with over 15 years of clinical and research expertise in rare neuroimmunological disorders. He established the Neuroimmunology Clinic and Research Laboratory at Massachusetts General Hospital and is the Research Director in the Division of Neuroimmunology and Neuroinfectious Disease. Previously, Dr. Levy was on the faculty at Johns Hopkins University and was the founding Director of their Neuromyelitis Optica Clinic. Clinically, Dr. Levy cares for patients with MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (TM). Dr. Levy is also the principal investigator (PI) on numerous patient studies and drug trials for new and improved treatments for these disorders. In 2022, Dr. Levy became the lead principal investigator for the two worldwide clinical trials in MOG antibody disease. In the lab, Dr. Levy's research focuses on the development of animal models of NMO and MOG with the goal of tolerization as a sustainable long-term treatment. Dr. Levy has more than 200 peer-reviewed research articles, reviews and editorials, and 3 patents covering NMO tolerization therapy, TM diagnostics, and stem cell regeneration approaches.00:00 Welcome01:02 Optic Neuritis Basics02:27 Causes and Percentages03:14 MS vs NMO vs MOG06:07 Workup and Testing07:51 Acute Attack Treatment09:30 Recovery and Vision Measures11:57 Pivikto Neuroprotection15:30 Efgartigimod vs Plasma Exchange17:59 Repair vs Remyelination20:15 Q-Cells and Stem Cell Delivery22:22 Closing

Karen shares how her husband gave her the silent treatment for an entire week immediately after celebrating their 38th wedding anniversary. Got a dilemma? Call 1-800-DR-LAURA / 1-800-375-2872 or make an appointment at DrLaura.com Follow on social media: Facebook.com/DrLaura Instagram.com/DrLauraProgram YouTube.com/DrLaura Join the Dr. Laura Family!! >> Receive my weekly newsletter, perks, and more! Sign up now, it's FREE > DrLaura.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.